Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

EGFR inhibitors for lung cancer can cause severe skin issues.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Certain topical drugs can regrow hair in mice.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

EGFR inhibitors can cause skin eruptions different from acne, needing specific management.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Baricitinib helps treat severe hair loss in people over 65.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Deuruxolitinib effectively promotes hair regrowth in alopecia areata.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.